Edition:
India

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

50.35USD
12:14am IST
Change (% chg)

$-1.64 (-3.15%)
Prev Close
$51.99
Open
$50.21
Day's High
$51.49
Day's Low
$48.41
Volume
375,051
Avg. Vol
356,401
52-wk High
$81.48
52-wk Low
$48.41

Latest Key Developments (Source: Significant Developments)

NuVasive Comments On Expected Impact Of U.S. Tax Reform
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Nuvasive Inc ::NUVASIVE COMMENTS ON EXPECTED IMPACT OF U.S. TAX REFORM.NUVASIVE INC - ‍SAVINGS FROM TAX REFORM EXPECTED TO BOOST FORWARD-LOOKING FREE CASH FLOW, NON-GAAP EPS IN EXCESS OF 10 % PER YEAR BEGINNING IN 2018​.NUVASIVE -EARLY ANALYSIS INDICATE NON-GAAP TAX RATE TO DROP INTO LOW 20 PERCENT RANGE IN 2018 AND IN FUTURE PERIODS CONVERGE TO 20 PERCENT NON-GAAP TAX RATE.  Full Article

Nuvasive To Acquire Safepassage
Wednesday, 13 Dec 2017 

Dec 12 (Reuters) - Nuvasive Inc ::NUVASIVE TO ACQUIRE SAFEPASSAGE.NUVASIVE INC - TERMS OF DEAL WERE NOT DISCLOSED..NUVASIVE INC - NUVASIVE EXPECTS TRANSACTION TO BE ACCRETIVE TO COMPANY'S NON-GAAP EARNINGS PER SHARE (EPS) IN 2018 AND BEYOND.NUVASIVE INC - CO ALSO EXPECTS DEAL TO SUPPORT LONGER-TERM TARGETS FOR REVENUE GROWTH AND EXPANSION OF ITS NON-GAAP OPERATING AND EBITDA MARGINS.  Full Article

NuVasive announces $100 million share repurchase program
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - NuVasive Inc :NuVasive announces $100 million share repurchase program.NuVasive Inc - ‍intends to fund repurchases under share repurchase program from cash on hand, cash generated from operations​.NuVasive Inc - also ‍intends to fund repurchases from available borrowing under its existing credit facility​.  Full Article

NuVasive Inc reports Q3 GAAP earnings per share $0.64
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - NuVasive Inc :NuVasive reports third quarter 2017 financial results.Q3 non-GAAP earnings per share $0.52.Q3 GAAP earnings per share $0.64.Q3 revenue rose 3.2 percent to $247.4 million.NuVasive Inc sees ‍revenue​ and non-GAAP revenue of $1,030 million for fy 2017.NuVasive Inc sees earnings per share of $1.37 for fy 2017 and adjusted earnings per share of $1.91 for fy 2017.  Full Article

NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Nuvasive Inc ::NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology.Says ‍received expanded 510(K) clearance from U.S. FDA for co's precice system​.Says the ‍system is now indicated for bone transport of long bones in addition to limb lengthening​.  Full Article

NuVasive files lawsuit against Patrick S. Miles
Wednesday, 11 Oct 2017 

Oct 10 (Reuters) - Alphatec Holdings Inc :Nuvasive files lawsuit against patrick s. Miles to protect corporate assets and stakeholders' interests.Nuvasive inc - ‍filed a lawsuit in delaware chancery court against patrick s. Miles, former vice chairman of co and member of co's board of directors​.Nuvasive inc says lawsuit asserts that ‍miles' resignation from co was "in violation of his contractual obligations to nuvasive"​.  Full Article

NuVasive - sees 2016 revenue of approximately $962 mln
Wednesday, 27 Jul 2016 

NuVasive Inc : FY2016 earnings per share view $1.51, revenue view $936.0 million -- Thomson Reuters I/B/E/S . NuVasive reports second quarter 2016 financial results . Q2 non-GAAP earnings per share $0.40 . Q2 GAAP earnings per share $0.57 . Q2 revenue rose 16.4 percent to $236.2 million . Sees 2016 revenue of approximately $962.0 million . Sees 2016 non-GAAP diluted earnings per share of approximately $1.64 .Sees 2016 non-GAAP operating profit margin of approximately 16.0 pct.  Full Article

Nuvasive agrees to settle patent litigation with Medtronic
Friday, 1 Jul 2016 

Nuvasive Inc : Nuvasive agrees to settle patent litigation with Medtronic . Nuvasive and Medtronic reached agreement on terms for settlement of previously disclosed patent infringement lawsuits . Company and Medtronic intend to enter into a definitive settlement agreement within 15 days . Reached agreement on terms for withdrawal from proceedings in United States patent and trademark office . After settlement agreement, company will make a one-time payment of $45 million to medtronic .Parties will release each other from any and all liabilities arising out of litigation.  Full Article

NuVasive to acquire Biotronic NeuroNetwork
Tuesday, 7 Jun 2016 

NuVasive Inc : NuVasive to acquire Biotronic NeuroNetwork . Deal for $98 million . Board of directors of both companies have unanimously approved transaction . Deal immediately accretive to non-GAAP diluted earnings, aligned to operating and EBITDA margin expansion . NuVasive expects to fund acquisition with existing cash on hand .NuVasive expects transaction to be significantly accretive in 2017 and beyond.  Full Article

NuVasive Inc announces proposed offering of $550 million of convertible senior notes due 2021
Thursday, 10 Mar 2016 

NuVasive Inc:Announces proposed offering of $550 million of convertible senior notes due 2021.  Full Article

BRIEF-NuVasive Comments On Expected Impact Of U.S. Tax Reform

* NUVASIVE INC - ‍SAVINGS FROM TAX REFORM EXPECTED TO BOOST FORWARD-LOOKING FREE CASH FLOW, NON-GAAP EPS IN EXCESS OF 10 % PER YEAR BEGINNING IN 2018​